Log in

NYSEARCA:YCLProShares Ultra Yen Stock Price, Forecast & News

-0.08 (-0.14 %)
(As of 07/6/2020 04:00 PM ET)
Today's Range
Now: $55.74
50-Day Range
MA: $55.76
52-Week Range
Now: $55.74
Volume100 shs
Average Volume1,821 shs
Market Capitalization$2.79 million
P/E RatioN/A
Dividend Yield0.00%

Currency Exposure of YCL

Basic Details

Issuer ProShares
Fund NameProShares Ultra Yen
Tax ClassificationPartnership
Inception Date11/24/2008
Fund ManagerJeffrey Ploshnick

Fund Focus

Asset ClassCurrency
BenchmarkJPY/USD Exchange Rate
CategoryJapanese Yen
FocusJapanese Yen
Development LevelDeveloped Markets

Fund Statistics

Assets Under Management$2.79 million
Average Daily Volume$380.10

ETF Expenses

Management Fee0.95%
Other Expenses0.06%
Total Expenses1.01%
Fee Waiver0.00%
Net Expenses1.01%

Administrator, Advisor and Custodian

AdministratorBrown Brothers Harriman & Co.
AdvisorProShare Advisors LLC
CustodianBrown Brothers Harriman & Co.
DistributorSEI Investments Distribution Co.
Transfer AgentBrown Brothers Harriman & Co.
TrusteeWilmington Trust Company
Lead Market MakerVirtu Financial

Receive YCL News and Ratings via Email

Sign-up to receive the latest news and ratings for YCL and its competitors with MarketBeat's FREE daily newsletter.

ProShares Ultra Yen (NYSEARCA:YCL) Frequently Asked Questions

How has ProShares Ultra Yen's stock been impacted by COVID-19 (Coronavirus)?

ProShares Ultra Yen's stock was trading at $59.56 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, YCL shares have decreased by 6.4% and is now trading at $55.74. View which stocks have been most impacted by Coronavirus.

Has ProShares Ultra Yen been receiving favorable news coverage?

News headlines about YCL stock have trended negative on Tuesday, InfoTrie Sentiment reports. The research group identifies negative and positive press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. ProShares Ultra Yen earned a news sentiment score of -2.1 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View the latest news about ProShares Ultra Yen.

What is ProShares Ultra Yen's stock symbol?

ProShares Ultra Yen trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "YCL."

How do I buy shares of ProShares Ultra Yen?

Shares of YCL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is ProShares Ultra Yen's stock price today?

One share of YCL stock can currently be purchased for approximately $55.74.

How big of a company is ProShares Ultra Yen?

ProShares Ultra Yen has a market capitalization of $2.79 million.

This page was last updated on 7/7/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.